4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-053064
Chief Executive Officer sold 56,325 shares at $31.83 ($1,792,825)
- Chief Executive Officer acquired 56,325 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2019-10-10 | Option exercise | +56,325 | $5.20 | $292,890 | 2,178,228 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2019-10-10 | Sale | −56,325 | $31.83 | $1,792,825 | 2,121,903 | D |
| Derivatives | |||||||
| Anzalone Christopher Richard Chief Executive Officer | 2019-10-10 | Option exercise · Stock Option (right to buy) | −56,325 | 945,543 | D | ||
| Open-market sales · 56,325 sh · avg $31.83 · $1,792,825 | |||||||
Loading xslF345X03/doc4.xml…